Kaitlin Kelly
PharmD, BCOP
Rotations
Multiple Myeloma/Lymphoma Clinic
Education
PharmD: Midwestern University Chicago
Residency Training
PGY-1: Advocate Illinois Masonic Medical Center
PGY-2 Oncology: University of Chicago Medicine
Practice Interests
Multiple Myeloma and Lymphoma
Professional Affiliation
Hematology/Oncology Pharmacy Association (HOPA)
American Society of Health-System Pharmacists (ASHP)
Recent Publications
Kelly K, Cooperrider J, Bishop MR, Kosuri S, Jakubowiak A, Derman BA. Intrathecal chemotherapy for ciltacabtagene autoleucel-associated movement and neurocognitive toxicity. Blood Adv. Published online May 7, 2025.
Swamy V, Kelly K, Koyner J, Derman D, Bonilla M. Chimeric Antigen Receptor T-Cell Therapy in Dialysis Dependent Patients with Multiple Myeloma: Insights from a Five-Case Series. Kidney Med. 2025
Marable M, Kelly K, Cooperrider JH, Jakubowiak A, Derman BA. Rapid high-dose cyclophosphamide as bridging treatment for advanced therapies in multiple myeloma. EJHaem. 2024;5(6):1260-1264.
Padmaraju K, Kelly K, Jakubowiak AJ, Derman BA. Evaluation of administration-related reactions with subcutaneous daratumumab with and without premedication. Oncologist. 2024;29(9):806-810.
Academic and/or National Presentations
Novel Therapies in Lymphoma: CELMoDs and BTK Degraders: International Ultmann Chicago Lymphoma
Practical Aspects of Bispecific T-cell Engagers: Supportive Care Strategies: International Ultmann Chicago Lymphoma
Supportive Care for Patients with cHL Receiving Immunotherapy: Differentiating Checkpoint Inhibitors vs Antibody Drug Conjugates: International Ultmann Chicago Lymphoma
Best Practices in Bispecifics: Hematology Oncology Pharmacy Conference - Midwest
Balancing the Scales: Best Practices, Challenges, and Evolving Roles in Oncology Residency Precepting: Oncology Pharmacy Network
Toxicities of New Therapies: Lymphoma and Multiple Myeloma: Practice Updates in Hematology and Oncology by University of Chicago Medicine
Updates in Bispecific T-cell Engagers: Combination and novel Therapy: Annual Updates from ASH 2024 by University of Chicago Medicine
Updates in Hematology: Menin Inhibitors and Bispecific T-cell Engagers: Annual Updates from ASH 2024 by University of Chicago Medicine
Current Research
Optimization of 6-mercaptopurine and oral methotrexate dosing and monitoring during maintenance therapy for the treatment of acute lymphoblastic leukemia
The Influence of Gut Decontamination Prophylactic Antibiotics on Allogeneic Hematopoietic Stem Cell Transplant Outcomes